Metsera纳斯达克上市：首日大涨47%，市值28亿美元，主治肥胖症

雷递网2025-02-01

雷递网雷建平 2月1日临床阶段的生物技术公司Metsera(股票代码：“MTSR”）昨日在美国纳斯达克上市。Metsera发行价为18美元，发行1528万股，募资总额为2.75亿美元。Metsera开盘价为25.5美元，较发行价上涨41.7%；收盘价为26.5美元，较发行价上涨47%；以收盘价计算，公司市值为27.81亿美元。近期，医疗保健及生物医药企业频频在美股上市，Ascentage ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2508925197?lang=zh_CN&edition=full","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250201/6387403112880683398066864.jpeg","is_english":false,"pubTime":"2025-02-01 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2508925197","market":"hk","top_or_hot":-1,"title":"Metsera纳斯达克上市：首日大涨47%，市值28亿美元，主治肥胖症","media":"雷递网","content":"<div>\n<p>雷递网 雷建平 2月1日临床阶段的生物技术公司Metsera(股票代码：“MTSR”）昨日在美国纳斯达克上市。Metsera发行价为18美元，发行1528万股，募资总额为2.75亿美元。Metsera开盘价为25.5美元，较发行价上涨41.7%；收盘价为26.5美元，较发行价上涨47%；以收盘价计算，公司市值为27.81亿美元。近期，医疗保健及生物医药企业频频在美股上市，Ascentage ...</p>\n\n<a href=\"https://www.leinews.com/n28924/detail.html\">网页链接</a>\n\n</div>\n","source":"leinews_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Metsera纳斯达克上市：首日大涨47%，市值28亿美元，主治肥胖症</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMetsera纳斯达克上市：首日大涨47%，市值28亿美元，主治肥胖症\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-01 18:26 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.leinews.com/n28924/detail.html><strong>雷递网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>雷递网 雷建平 2月1日临床阶段的生物技术公司Metsera(股票代码：“MTSR”）昨日在美国纳斯达克上市。Metsera发行价为18美元，发行1528万股，募资总额为2.75亿美元。Metsera开盘价为25.5美元，较发行价上涨41.7%；收盘价为26.5美元，较发行价上涨47%；以收盘价计算，公司市值为27.81亿美元。近期，医疗保健及生物医药企业频频在美股上市，Ascentage ...</p>\n\n<a href=\"https://www.leinews.com/n28924/detail.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_NQ","symbol_name":"NQ100指数","start_time":0,"source_url":"https://www.leinews.com/n28924/detail.html","article_id":"2508925197","we_media_id":null,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250201/6387403112880683398066864.jpeg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2508925197","pubTimestamp":1738405576,"columns":[],"sourceInfo":{"source_id":"leinews_highlight","name":"雷帝触网"},"weMediaInfo":null,"summary":"临床阶段的生物技术公司Metsera(股票代码：“MTSR”）昨日在美国纳斯达克上市。Metsera发行价为18美元，发行1528万股，募资总额为2.75亿美元。Metsera开盘价为25.5美元，较发行价上涨41.7%；收盘价为26.5美元，较发行价上涨47%；以收盘价计算，公司市值为27.81亿美元。","collect":0,"end_time":0,"defaultTopTitle":"leinews.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{".IXIC":"NASDAQ Composite","MTSR":"Metsera Inc.","03086":"华夏纳指","TQQQ":"纳指三倍做多ETF","BK4007":"制药","ARTL":"Artelo Biosciences, Inc.","PSQ":"做空纳斯达克100指数ETF-ProShares","TSYW.SI":"TESLA 3xLongSG261006","SQQQ":"纳指三倍做空ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","USAW.SI":"AMZN 3xLongSG261006","NDX":"纳斯达克100指数","NVIW.SI":"NVDA 3xLongSG261006","QID":"两倍做空纳斯达克指数ETF-ProShares","BK1147":"投资银行业与经纪业","USJW.SI":"ALPHAB 3xLongSG261006"},"translate_title":"Metsera Nasdaq listing: rose 47% on the first day, with a market value of US $2.8 billion, mainly treating obesity","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":1,"PSQ":0.6,"USAW.SI":0.6,"03086":1,"TSYW.SI":0.6,"MTSR":1,"TQQQ":0.6,"NQmain":0.6,"NDX":1,"NVIW.SI":0.6,"QID":0.6,"ARTL":1,"SQQQ":0.6,"USJW.SI":0.6,"QLD":0.6,"MNQmain":0.6},"content_text":"雷递网 雷建平 2月1日临床阶段的生物技术公司Metsera(股票代码：“MTSR”）昨日在美国纳斯达克上市。Metsera发行价为18美元，发行1528万股，募资总额为2.75亿美元。Metsera开盘价为25.5美元，较发行价上涨41.7%；收盘价为26.5美元，较发行价上涨47%；以收盘价计算，公司市值为27.81亿美元。近期，医疗保健及生物医药企业频频在美股上市，Ascentage Pharma刚以1.26亿美元实现纳斯达克上市。日前，Beta Bionics又募资2.04亿美元。Maze Therapeutics也与Metsera同一天上市，发行价为16美元，募资总额为1.4亿美元。9个月净亏1.56亿美元Metsera由风险投资公司ARCH Venture和投资公司Population Health Partners于2022年创立，正在开发基于 GLP-1 机制和其他生物靶点的注射和口服药物来治疗肥胖症。GLP-1药物有助于减缓消化并通过引发饱腹感来减少饥饿感，正在对其进行研究，以查看它们是否也可以通过其他方式改善健康。预计到2030年代初全球减肥药市场价值将达到约1500亿美元，这吸引越来越多的投资者对瞄准这一快速增长领域的公司的兴趣。招股书显示，Metsera暂无营收，其2023年运营亏损4367万美元，净亏损为4721万美元；2024年前9个月营收为运营亏损1.6亿美元，净亏损1.56亿美元。刚完成2.15亿美元B系列轮融资2024年11月，Metsera刚完成2.15亿美元的B系列轮融资，由Wellington Management和Venrock牵头的融资，由Fidelity Management & Research Company、T. Rowe Price、Janus Henderson等公司参与。IPO前， ARCH Venture Partners持股28.1%，Validae Health持股14.6%，FMR持股8.1%；GV 2023持股为5.7%，MC Longevity持股5.2%，Newpath Partners持股5.6%，SVF II US Aggregator持股为5.5%。IPO后，ARCH Venture Partners持股23.5%，Validae Health持股12.2%，FMR持股6.8%；GV 2023持股4.7%，MC Longevity持股4.3%，Newpath Partners持股4.7%，SVF II US Aggregator持股为4.6%。以下是减肥药企业Metsera路演PPT：———————————————雷递由媒体人雷建平创办，若转载请写明来源。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2508925197","isCrawlerRequest":true}